Business
cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer
cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, has appointed Jim Alecxih as Chief Executive Officer. Alecxih, a recognized commercial leader in the medical device industry, brings more than 30 years of experience advancing transformative surgical technologies worldwide, including a distinguished
About this update from Intuitive Surgical, Inc.
[{"type":"text","content":"GRAND RAPIDS, Mich., June 24, 2025 /PRNewswire/ -- cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the MIRA Surgical System authorized by the FDA through the De Novo regulatory pathway, has appointed Jim Alecxih as Chief Executive Officer. Alecxih, a recognized commercial leader in the medical device industry, brings more than 30 years of experience advancing transformative surgical technologies worldwide, including a distinguished tenure at Intuitive Surgical, where he played a pivotal role in the adoption and growth of the da Vinci Surgical System.","length":691,"tagName":"p"},{"type":"image","alt":"cultivate(MD) logo (PRNewsfoto/cultivate(MD))","displaySize":"","headline":null,"caption":"cultivate(MD) logo (PRNewsfoto/cultivate(MD))","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":90,"url":"https://media.zenfs.com/en/prnewswire.com/07cb3a494c036d5fba7df294a8c92d15"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/u9DYEAnjB7oOUIsPzSjhtQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE1OTtjZj13ZWJw/https://media.zenfs.com/en/prnewswire.com/07cb3a494c036d5fba7df294a8c92d15","width":400,"height":90}},"href":"https://mma.prnewswire.com/media/1914331/cultivateMD_Logo_Fitted_Canvas__1_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"Virtual Incision is now preparing for the accelerated development and commercialization of their next system, M2, with plans for a series of FDA submissions in various specialties. M2 is a miniaturized, single port surgical robotic system designed to be smart, simple and small, with the potential to minimize the cost and complexity of current mainframe cart-based surgical robotic systems. M2 will be optimized to bring robotic-assisted surgery to hospitals and surgical settings that lack access to surgical robotics technologies.","length":533,"tagName":"p"},{"type":"text","content":"Mr. Alecxih previously served as CEO of DH Medical, an AI software company, and has held executive leadership roles across multiple healthcare startups and growth-stage companies. At Intuitive Surgical, he led U.S. sales and was instrumental in driving adoption of robotic-assisted surgery among hospitals and health systems nationwide."...